A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal
to Mild Alzheimer's Disease
Does the drug prodromal help patients with Alzheimer's disease?
Basic Study Information
Purpose:Location: University of Rochester; AD-CARE
This is a phase II, randomized, placebo-controlled, double-blind study to evaluate
efficacy and safety of RO7105705 in participants with prodromal to mild Alzheimer's
An optional 96-week open-label extension period will be available to participants
complete the double-blind treatment period and who, in the judgment of the investigator,
would potentially benefit from open-label RO7105705 treatment.
Study Contact InformationStudy Coordinator: Reference Study ID: GN39763 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search